Uncategorized Archives | MPM BioImpact

3rd December 2024

Watch: MPM BioImpact Founder and Managing Partner Ansbert Gadicke on the BioVenture Voices Podcast with Chris Garabedian

18th November 2024

MPM BioImpact-Founded Company, Syndax, Announces FDA Approval of Revuforj® (revumenib)

14th November 2024

Dr. Michael Ehlers Joins MPM BioImpact as Entrepreneur Partner – Endpoints News

14th November 2024

Michael Ehlers, M.D., Ph.D., Experienced R&D Leader and Accomplished Biotechnology Executive, Appointed as MPM BioImpact Entrepreneur Partner